219 related articles for article (PubMed ID: 20538141)
1. Management implications of massive left ventricular hypertrophy in hypertrophic cardiomyopathy significantly underestimated by echocardiography but identified by cardiovascular magnetic resonance.
Maron MS; Lesser JR; Maron BJ
Am J Cardiol; 2010 Jun; 105(12):1842-3. PubMed ID: 20538141
[TBL] [Abstract][Full Text] [Related]
2. Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy.
Maron MS; Finley JJ; Bos JM; Hauser TH; Manning WJ; Haas TS; Lesser JR; Udelson JE; Ackerman MJ; Maron BJ
Circulation; 2008 Oct; 118(15):1541-9. PubMed ID: 18809796
[TBL] [Abstract][Full Text] [Related]
3. [The role of magnetic resonance in studying hypertrophic cardiomyopathy: the echocardiographic correlations and clinical implications].
Rapezzi C; Fattori R; Castriota F; Passarelli P; Magnani G; Galiè N; Ferlito M; Bertaccini P; Branzi A; Gavelli G
Cardiologia; 1994 Jan; 39(1):7-15. PubMed ID: 8020058
[TBL] [Abstract][Full Text] [Related]
4. [Clinical significance of magnetic resonance and echocardiographic correlations in the evaluation of hypertrophic cardiomyopathy].
Fattori R; Rapezzi C; Castriota F; Magnani G; Bertaccini P; Galiè N; Magnani B; Gavelli G
Radiol Med; 1994; 88(1-2):36-43. PubMed ID: 8066253
[TBL] [Abstract][Full Text] [Related]
5. Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling.
Rudolph A; Abdel-Aty H; Bohl S; Boyé P; Zagrosek A; Dietz R; Schulz-Menger J
J Am Coll Cardiol; 2009 Jan; 53(3):284-91. PubMed ID: 19147047
[TBL] [Abstract][Full Text] [Related]
6. [Clinical significance of late gadolinium enhancement on cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy].
Dumont CA; Monserrat L; Soler R; Rodríguez E; Fernández X; Peteiro J; Bouzas B; Piñón P; Castro-Beiras A
Rev Esp Cardiol; 2007 Jan; 60(1):15-23. PubMed ID: 17288951
[TBL] [Abstract][Full Text] [Related]
7. Significance and relation between magnitude of left ventricular hypertrophy and heart failure symptoms in hypertrophic cardiomyopathy.
Maron MS; Zenovich AG; Casey SA; Link MS; Udelson JE; Aeppli DM; Maron BJ
Am J Cardiol; 2005 Jun; 95(11):1329-33. PubMed ID: 15904638
[TBL] [Abstract][Full Text] [Related]
8. Relation of left ventricular chamber stiffness at rest to exercise capacity in hypertrophic cardiomyopathy.
Dumont CA; Monserrat L; Peteiro J; Soler R; Rodriguez E; Bouzas A; Fernández X; Pérez R; Bouzas B; Castro-Beiras A
Am J Cardiol; 2007 May; 99(10):1454-7. PubMed ID: 17493479
[TBL] [Abstract][Full Text] [Related]
9. Plasma N-terminal pro-brain natriuretic peptide: a marker of left ventricular hypertrophy in hypertrophic cardiomyopathy.
Brito D; Matias JS; Sargento L; Cabral MJ; Madeira HC
Rev Port Cardiol; 2004 Dec; 23(12):1557-82. PubMed ID: 15732658
[TBL] [Abstract][Full Text] [Related]
10. Imaging hypertrophic heart diseases with cardiovascular MR.
Proctor RD; Shambrook JS; McParland P; Peebles CR; Brown IW; Harden SP
Clin Radiol; 2011 Feb; 66(2):176-86. PubMed ID: 21216334
[TBL] [Abstract][Full Text] [Related]
11. Disparity between unusual left ventricular morphology and clinical presentation and course in hypertrophic cardiomyopathy.
Maron BJ; Lindberg J; Haas TS; Kitner C; Lesser JR
Am J Cardiol; 2010 Jun; 105(11):1643-4. PubMed ID: 20494677
[No Abstract] [Full Text] [Related]
12. Cardiac magnetic resonance in hypertrophic cardiomyopathy: current state of the art.
Kwon DH; Desai MY
Expert Rev Cardiovasc Ther; 2010 Jan; 8(1):103-11. PubMed ID: 20014937
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of magnetic resonance imaging to distinguish hypertensive and hypertrophic cardiomyopathy.
Puntmann VO; Jahnke C; Gebker R; Schnackenburg B; Fox KF; Fleck E; Paetsch I
Am J Cardiol; 2010 Oct; 106(7):1016-22. PubMed ID: 20854967
[TBL] [Abstract][Full Text] [Related]
14. Variables associated with contrast-enhanced cardiovascular magnetic resonance in hypertrophic cardiomyopathy: clinical implications.
Payá E; Marín F; González J; Gimeno JR; Feliu E; Romero A; Ruiz-Espejo F; Roldán V; Climent V; de la Morena G; Valdés M
J Card Fail; 2008 Jun; 14(5):414-9. PubMed ID: 18514934
[TBL] [Abstract][Full Text] [Related]
15. Right ventricular involvement in hypertrophic cardiomyopathy.
Maron MS; Hauser TH; Dubrow E; Horst TA; Kissinger KV; Udelson JE; Manning WJ
Am J Cardiol; 2007 Oct; 100(8):1293-8. PubMed ID: 17920373
[TBL] [Abstract][Full Text] [Related]
16. [Platelet aggregation in patients with hypertrophic cardiomyopathy].
Riazanov AS; Gabbasov ZA; Iurenev AP
Ter Arkh; 2000; 72(8):36-8. PubMed ID: 11019425
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Maximal Wall Thickness in Hypertrophic Cardiomyopathy Differs Between Magnetic Resonance Imaging and Transthoracic Echocardiography.
Bois JP; Geske JB; Foley TA; Ommen SR; Pellikka PA
Am J Cardiol; 2017 Feb; 119(4):643-650. PubMed ID: 27956002
[TBL] [Abstract][Full Text] [Related]
18. Hypertrophic Cardiomyopathy, Athlete's Heart, or Both: A Case of Hypertrophic Cardiomyopathy Regression.
Kebed KY; Bos JM; Anavekar NS; Mulvagh SL; Ackerman MJ; Ommen SR
Circ Cardiovasc Imaging; 2015 Jul; 8(7):e003312. PubMed ID: 26162782
[No Abstract] [Full Text] [Related]
19. [The current and emerging role of cardiovascular magnetic resonance imaging in hypertrophic cardiomyopathy].
Maron MS
Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Dec; 37(12):1057-63. PubMed ID: 20193172
[TBL] [Abstract][Full Text] [Related]
20. [Recomendations on management of left ventricular hypertrophy in athletes. The Working Group of Sports Cardiology of the French Society of Cardiology].
Brion R;
Arch Mal Coeur Vaiss; 2007 Mar; 100(3):195-206. PubMed ID: 17536423
[No Abstract] [Full Text] [Related]
[Next] [New Search]
